Fluor-18-Fdg

Fludeoxyglucose (18F) is a radiopharmaceutical used in positron emission tomography (PET) scans to detect metabolic activity in the body. It helps in diagnosing and monitoring various conditions by highlighting areas of high glucose metabolism.

Fludeoxyglucose (18F) is primarily used in PET scans to identify areas of high metabolic activity. This can be helpful in detecting cancer, evaluating heart function, and assessing brain activity. It is often used to monitor the effectiveness of treatments and to stage certain diseases.

Fludeoxyglucose (18F) works by being absorbed by cells with high metabolic rates, which can be detected by PET scans. This helps in visualizing areas of the body that may have abnormal metabolic activity, aiding in diagnosis and treatment planning.

Fludeoxyglucose (18F) should be handled with care due to its radioactive nature. It is administered intravenously by healthcare professionals in controlled environments. Patients should follow the instructions provided by their healthcare provider regarding preparation and post-procedure care.

Fludeoxyglucose (18F) may interact with certain medications or substances that affect glucose metabolism. It is important to inform your healthcare provider about all medications and supplements you are taking before undergoing a PET scan with Fludeoxyglucose (18F).